Genetic testing enhances retinoblastoma risk prediction

11/29/2011 | Oncology Nurse Advisor online

Genetic testing of children with retinoblastoma reduced the number of disease risk screenings required for their relatives, according to a study involving patients at Texas Children's Cancer Center in Houston. "By systematically including genetic testing in the care of retinoblastoma patients, we could eliminate the need for such screening in the majority of relatives and save both health care costs and potential risks of the anesthesia," said senior study author Dr. Sharon E. Plon.

View Full Article in:

Oncology Nurse Advisor online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD